e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Pulmonary circulation: clinical pulmonary hypertension I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary veno-occlusive disease (PVOD) induced by chemotherapy: Experience from the French PH network and literature review
S. Günther, M. C. Chaumais, P. Dorfmüller, X. Jaïs, L. Savale, E. Artaud-Macari, F. Perros, S. Cohen-Kaminsky, O. Sitbon, M. Humbert, G. Simmoneau, D. Montani (Le Kremlin Bicêtre, Le Plessis Robinson, France)
Source:
Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Session:
Pulmonary circulation: clinical pulmonary hypertension I
Session type:
Thematic Poster Session
Number:
2635
Disease area:
Pulmonary vascular diseases, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Günther, M. C. Chaumais, P. Dorfmüller, X. Jaïs, L. Savale, E. Artaud-Macari, F. Perros, S. Cohen-Kaminsky, O. Sitbon, M. Humbert, G. Simmoneau, D. Montani (Le Kremlin Bicêtre, Le Plessis Robinson, France). Pulmonary veno-occlusive disease (PVOD) induced by chemotherapy: Experience from the French PH network and literature review. Eur Respir J 2013; 42: Suppl. 57, 2635
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
The definition of pulmonary hypertension: history, practical implications and current controversies
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014
Five-years experience with high urgency allocation program for lung and heart-lung transplantation in pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centre
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
An overview of thrombolytic treatment for pulmonary embolism: A single center experience
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Does Wells score documentation really prevent excessive CTPA requests in a teaching hospital? A retrospective study in 800 patients
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014
Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics
Source: Eur Respir J 2005; 25: 783-788
Year: 2005
Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
CPFE (combined pulmonary fibrosis and emphysema): A case series
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
Source: Eur Respir J 2012; 39: 945-955
Year: 2012
Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014
Portopulmonary hypertension in United Kingdom: A contemporary, national, observational study
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Global burden of chronic thromboembolic pulmonary hypertension (CTEPH): An epidemiological analysis
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Riociguat for the treatment of pulmonary hypertension: Safety data from the EXPERT registry
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Issues related to the management and therapy of paediatric pulmonary hypertension
Source: Eur Respir Rev 2010 19: 331-339
Year: 2010
Measurement of small pulmonary vessels by using computed tomography (CT) in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept